Cargando…
Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037534/ https://www.ncbi.nlm.nih.gov/pubmed/27618090 http://dx.doi.org/10.3390/nu8090549 |
_version_ | 1782455757310001152 |
---|---|
author | Li, Xue Cai, Xiaxia Ma, Xiaotao Jing, Lulu Gu, Jiaojiao Bao, Lei Li, Jun Xu, Meihong Zhang, Zhaofeng Li, Yong |
author_facet | Li, Xue Cai, Xiaxia Ma, Xiaotao Jing, Lulu Gu, Jiaojiao Bao, Lei Li, Jun Xu, Meihong Zhang, Zhaofeng Li, Yong |
author_sort | Li, Xue |
collection | PubMed |
description | Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable dietary plan for overweight T2DM patients. A randomized control trial, registered under ClinicalTrials.gov (Identification code: NCT01495052), was carried out among adult T2DM patients. A subgroup of 298 overweight subjects was selected and received a 30-day centralized intervention and 1-year free-living follow-up. Participants were randomly allocated to one of the following four groups. The usual care group (n = 60) received no intervention; the healthy diet group (n = 79) received a low-fat and high-fiber diet (“healthy diet”); the 50 g-oats group (n = 80) and 100 g-oats group (n = 79) received the “healthy diet” with the same amount of cereals replaced by 50 g and 100 g oats respectively. Anthropometric, blood glycemic and lipid variables were measured. For the 30-day intervention, significant differences in the changes of FPG (fasting plasma glucose), PPG (postprandial plasma glucose), HbA1c (glycosylated hemoglobin), HOMA-IR (homeostasis model assessment of insulin resistance), TC (total cholesterol), TG (total triglycerides), and LDL-c (low-density lipoprotein cholesterol) were observed among the four groups. Compared to the healthy diet group, the 50 g-oats group had a bigger reduction in PPG (mean difference (MD): −1.04 mmol/L; 95% CI: −2.03, −0.05) and TC (MD: −0.24 mmol/L; 95% CI: −0.47, −0.01); the 100 g-oats group had a bigger reduction in PPG (MD: −1.48 mmol/L; 95% CI: −2.57, −0.39), HOMA-IR (MD: −1.77 mU·mol/L(2); 95% CI: −3.49, −0.05), TC (MD: −0.33 mmol/L; 95% CI: −0.56, −0.10) and LDL-c (MD: −0.22 mmol/L; 95% CI: −0.41, −0.03). In the 1-year follow-up, greater effects in reducing weight (MD: −0.89 kg; 95% CI: −1.56, −0.22), HbA1c (MD: −0.64%; 95% CI: −1.19, −0.09) and TG (MD: −0.70 mmol/L; 95% CI: −1.11, −0.29) were observed in the 100 g-oats group. In conclusion, short- and long-term oat intake had significant effects on controlling hyperglycemia, lowering blood lipid and reducing weight. Our study provided some supportive evidence for recommending oat as a good whole grain selection for overweight diabetics. |
format | Online Article Text |
id | pubmed-5037534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50375342016-10-15 Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial Li, Xue Cai, Xiaxia Ma, Xiaotao Jing, Lulu Gu, Jiaojiao Bao, Lei Li, Jun Xu, Meihong Zhang, Zhaofeng Li, Yong Nutrients Article Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable dietary plan for overweight T2DM patients. A randomized control trial, registered under ClinicalTrials.gov (Identification code: NCT01495052), was carried out among adult T2DM patients. A subgroup of 298 overweight subjects was selected and received a 30-day centralized intervention and 1-year free-living follow-up. Participants were randomly allocated to one of the following four groups. The usual care group (n = 60) received no intervention; the healthy diet group (n = 79) received a low-fat and high-fiber diet (“healthy diet”); the 50 g-oats group (n = 80) and 100 g-oats group (n = 79) received the “healthy diet” with the same amount of cereals replaced by 50 g and 100 g oats respectively. Anthropometric, blood glycemic and lipid variables were measured. For the 30-day intervention, significant differences in the changes of FPG (fasting plasma glucose), PPG (postprandial plasma glucose), HbA1c (glycosylated hemoglobin), HOMA-IR (homeostasis model assessment of insulin resistance), TC (total cholesterol), TG (total triglycerides), and LDL-c (low-density lipoprotein cholesterol) were observed among the four groups. Compared to the healthy diet group, the 50 g-oats group had a bigger reduction in PPG (mean difference (MD): −1.04 mmol/L; 95% CI: −2.03, −0.05) and TC (MD: −0.24 mmol/L; 95% CI: −0.47, −0.01); the 100 g-oats group had a bigger reduction in PPG (MD: −1.48 mmol/L; 95% CI: −2.57, −0.39), HOMA-IR (MD: −1.77 mU·mol/L(2); 95% CI: −3.49, −0.05), TC (MD: −0.33 mmol/L; 95% CI: −0.56, −0.10) and LDL-c (MD: −0.22 mmol/L; 95% CI: −0.41, −0.03). In the 1-year follow-up, greater effects in reducing weight (MD: −0.89 kg; 95% CI: −1.56, −0.22), HbA1c (MD: −0.64%; 95% CI: −1.19, −0.09) and TG (MD: −0.70 mmol/L; 95% CI: −1.11, −0.29) were observed in the 100 g-oats group. In conclusion, short- and long-term oat intake had significant effects on controlling hyperglycemia, lowering blood lipid and reducing weight. Our study provided some supportive evidence for recommending oat as a good whole grain selection for overweight diabetics. MDPI 2016-09-07 /pmc/articles/PMC5037534/ /pubmed/27618090 http://dx.doi.org/10.3390/nu8090549 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Xue Cai, Xiaxia Ma, Xiaotao Jing, Lulu Gu, Jiaojiao Bao, Lei Li, Jun Xu, Meihong Zhang, Zhaofeng Li, Yong Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title | Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title_full | Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title_fullStr | Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title_full_unstemmed | Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title_short | Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial |
title_sort | short- and long-term effects of wholegrain oat intake on weight management and glucolipid metabolism in overweight type-2 diabetics: a randomized control trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037534/ https://www.ncbi.nlm.nih.gov/pubmed/27618090 http://dx.doi.org/10.3390/nu8090549 |
work_keys_str_mv | AT lixue shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT caixiaxia shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT maxiaotao shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT jinglulu shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT gujiaojiao shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT baolei shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT lijun shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT xumeihong shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT zhangzhaofeng shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial AT liyong shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial |